Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Personalised Risk Evaluation and Diagnosis in Cardiovascular Treatment for Acute Coronary Syndrome

Project description

AI for personalised heart care

Acute coronary syndrome (ACS) is a sudden blockage of blood flow to the heart. As a leading cause of death and disability worldwide, the medical community is under pressure to improve diagnosis and treatment. Supported by the Marie Skłodowska-Curie Actions programme, the PREDICT-X-ACS project aims to develop transformer-based, explainable AI models that provide clinicians with actionable insights. These models support personalised care, improving outcomes while addressing the limitations of traditional diagnostic tools. The overall goal is to advance precision medicine and reduce ACS-related mortality. The project will also drive innovation in healthcare technology aligned with global health and industry goals.

Objective

The Predict-X-ACS project, led by Dr. Deepa Joshi under the supervision of Prof. Lalit Garg at the University of Malta (UoM), aims to address the global burden of Acute Coronary Syndrome (ACS), a major contributor to cardiovascular disease (CVD). ACS, which results from the sudden reduction or blockage of blood flow to the heart, remains a leading cause of morbidity and mortality worldwide. This research integrates diverse data sources, including medical imaging, genomics, clinical records, environmental factors, and biomarkers, into a transformer-based, AI-powered precision medicine approach to enhance ACS care. The primary objective of the project is to develop scalable, explainable AI models that improve the diagnosis, treatment, and personalization of ACS care by overcoming the limitations of single-modal, non-transparent diagnostic tools. Through this multi-modal methodology, clinicians will be equipped with actionable insights, facilitating more accurate, individualized treatment plans and better patient outcomes. The project aligns directly with Sustainable Development Goal 3 (Good Health and Well-being) by contributing to the reduction of ACS-related mortality and improving patient care through the use of advanced medical technology. It also supports Sustainable Development Goal 9 (Industry, Innovation, and Infrastructure) by driving innovation in healthcare technology and promoting the application of cutting-edge AI methods in clinical practice. Continuous clinical validation and real-time feedback mechanisms ensure that the developed AI models are robust, adaptable, and ready for broad clinical implementation.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-TMA-MSCA-PF-EF - HORIZON TMA MSCA Postdoctoral Fellowships - European Fellowships

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-MSCA-2024-PF-01

See all projects funded under this call

Coordinator

UNIVERSITA TA MALTA
Net EU contribution
€ 256 642,80
Address
TAL OROQQ
MSD 2080 MSIDA
Malta
Region
Malta Malta Malta
Activity type
Higher or Secondary Education Establishments
Links
Total cost
No data

Partners (4)